USPTO trademark

CADEX GENOMICS

RegisteredUSPTOWord markClass 5Class 42Class 44

"CADEX GENOMICS" is a word mark owned by Cadex Genomics, Corp., filed at the USPTO on February 11, 2019. It is registered and covers classes 5, 42 and 44.

Official USPTO record
CADEX GENOMICS trademark as filed
As filed with the USPTO
Status
Registered
Since September 22, 2020
Filed
February 11, 2019
Registered
September 22, 2020
Expires
Not recorded
Application no.
88296676
Registration no.
6159028
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns CADEX GENOMICS

The owner and representative on file with the office.

Owner

Cadex Genomics, Corp.

Redwood City, United States

Representative

James K. Stronski

Crowell & Moring LLP

Goods and services

What the mark covers

The products and services CADEX GENOMICS is filed for, grouped by Nice class.

  • Medical diagnostic assays for testing of bodily fluids, namely, assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; Medical diagnostic test media in the form of reagents used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; medical diagnostic kits comprised of medical diagnostic reagents and assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy

  • Medical and scientific research in the field of medical diagnostic assays and clinical testing services for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; Research and development in the pharmaceutical and biotechnology fields, namely, research and development in the development of testing and information services related to medical diagnostic assays and clinical tests, and medical diagnostic kits used to conduct medical diagnostic assays and clinical tests

  • Medical testing for diagnostic or treatment purposes, namely, for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Courtesy reminder - sec. 8 (6-yr) e-mailed
  2. Registered-principal register
  3. Notice of acceptance of statement of use e-mailed
  4. Allowed principal register - sou accepted
  5. Statement of use processing complete
  6. Case assigned to intent to use paralegal
  7. Use amendment filed
  8. Teas statement of use received
  9. Noa e-mailed - sou required from applicant
  10. Official gazette publication confirmation e-mailed

10 earlier steps on the official record.

FAQ

About CADEX GENOMICS

Who owns the trademark "CADEX GENOMICS"?

The USPTO trademark "CADEX GENOMICS" (application 88296676) is owned by Cadex Genomics, Corp.

What is the status of "CADEX GENOMICS"?

Its status at the USPTO is: registered.

When was "CADEX GENOMICS" registered?

It was registered on September 22, 2020.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CADEX GENOMICS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2a3b-8580-737d-8737-d9012a48b59d
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a3b-8580-737d-8737-d9012a48b59d",
  "object": "trademark",
  "mark_text": "CADEX GENOMICS",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "88296676",
  "filing_date": "2019-02-11",
  "nice_classes": [
    5,
    42,
    44
  ],
  "owners": [
    {
      "name": "Cadex Genomics, Corp.",
      "entity_id": null
    }
  ]
}